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1. Introduction
Protons can more effectively produce biological damage as compared to photons, due to differences in the 
ionization processes between the radiation types (Tommasino and Durante 2015). Comparison of proton and 
photon treatment plans by the physical dose is therefore not enough. A conversion factor, the relative biological 
effectiveness (RBE), has been introduced in proton therapy to enable transferring of treatment protocols and 
experience gathered from γ- and x-ray irradiation (RBE Committee 1963). Clinical proton therapy applies a 
constant RBE of 1.1, even though the RBE is known to vary with dose, radiation quality and tissue type. These 
parameters are included in most phenomenological RBE-models for proton therapy, i.e. models based on results 
from proton beam in vitro experiments (Paganetti 2014).
The phenomenological RBE-models are typically based on the linear quadratic model (LQ-model), which 
model the dose-response by quantifying the αp  and βp  parameters (Rørvik et al 2018). The RBE at its maximum 
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Abstract
Cell experiments have shown the proton relative biological effectiveness (RBE) to vary with dose 
and linear energy transfer (LET), which has led to development of variable RBE models. The RBE is 
normally estimated from two independent functions, the RBEmax and RBEmin, describing the extreme 
RBE at low and high doses. While there is consensus that RBEmax increases with increasing LET, the 
RBEmin is not uniformly defined and its dependency on LET is deviating. In this work, we analysed 
this dependency and its sensitivity to variations of the experimental dose range.
We performed a literature search to find data from existing monoenergetic proton cell survival 
experiments with (α/β)x values below 5 Gy and dose averaged LET (LETd) values below 20 keV 
µm−1. From the experiments the doses and their corresponding survival data were extracted. Based 
on these data, multiple restricted databases were generated by sequential exclusion of low dose data 
in the experiments followed by a linear-quadratic (LQ) fit. The quadratic component from the LQ-fit 
was used to estimate RBEmin. The LETd dependency of RBEmin was determined by fitting a linear 
function to the RBEmin values estimated from the restricted databases.
Our analysis showed the LETd dependency of RBEmin to be significantly influenced by the 
experimental dose range. By including experiments with doses below 1 Gy in the database, we found 
that RBEmin increased with increasing LETd. By excluding the low dose experiments in our database, 
the RBEmin became constant for all LETd values. For an LETd value of 5 keV µm−1, a restricted 
database including the data with the lowest doses gave an RBEmin of 1.4  ±  0.1, while databases with 
only high dose data (>2 Gy) gave an RBEmin of 1.0  ±  0.1. None of our restricted databases gave a 
decreasing RBEmin with increasing LETd.
Our study showed that RBEmin has a small yet significant dependency on LETd for tissues with low 
(α/β)x ratio. The LETd dependency of RBEmin varied substantially with the experimental dose range. 
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and minimum can bea RBE model is then functions described by the variables RBEmax (=αp/αx) and RBEmin 
(=
√
βp/βx) (Schuemann et al 2018). These functions can be dependent on the radiation quality and tissue type, 
normally represented by the dose-averaged linear energy transfer (LETd) and the fractionation sensitivity of the 
photon radiation ((α/β)x), respectively.
The RBE-models agree on an increasing RBEmax with increasing LETd, but the dependency of RBEmin on 
LETd differ (Rørvik et al 2018). A recent review showed that 7 out of 12 phenomenological models assume a con-
stant RBEmin (equal to one) for all LETd values. However, in the models by Carabe et al (2012), Jones (2015) and 
Peeler (2016) the RBEmin increased with increasing LETd value, which is in contrast to the models by Belli et al 
(1997) and McNamara et al (2015), where the RBEmin decreased with increasing LETd (Rørvik et al 2018). The 
RBEmin relationships of the analytical biophysical models are also deviating, as shown by Manganaro et al (2017). 
According to their calculations, the repair–misrepair fixation (RMF) model, the microdosimetric-kinetic model 
(MKM) and the local effect model (LEM) predict an increasing, a constant and a decreasing relationship with 
LET, respectively. The differences in the phenomenological models mainly arise from the variations in the exper-
imental data, as the models’ assumptions are freely fitted to the experimental database. Even though all models 
are based on cell survival experiments, the experiments are not performed in a consistent manner between the 
experimental groups. They differ both in regard to the experimental setup such as dose range, dose rate and 
energy spectra and the analysis of the experimental data e.g. regression technique and uncertainty calculations.
A large amount of in vitro data exists for protons, which could be used to investigate different dependencies 
of the RBEmin functions. The in vitro data consist of multiple experiments of cell survival from various dose 
ranges, at a certain LETd value, and from which LQ-model parameters are extracted. The experimental setup 
varies between the different experiments, including dose range, as well as the regression method to determine the 
αp  and βp  parameters from the cell survival data. The fitted LQ-model parameters are highly dependent of the 
number of data points and the dose range of these points, as shown by Garcia et al (2006) for cells irradiated with 
photon radiation. Their analysis indicated that including data points with low doses increased the βp  parameter, 
as compared to when the regression was restricted to only high doses.
In this study we therefore analysed how the LETd dependency of RBEmin is influenced by the dose range of the 
proton in vitro experiments. We aimed to determine whether the common assumption of a constant RBEmin for 
all LETd values holds independently of dose range.
2. Materials and methods
We performed a literature search to find all survival experiments of cells irradiated in vitro by external proton 
beam therapy (per July 2018). In our work, an experiment was defined as a series of cell survival data from 
proton irradiations at different dose levels, but with a unique (α/β)x value and a single LETd. Consequently, each 
experiment represents a unique cell survival curve, which can be parameterised by fitting the LQ-model to the 
experimental data points.
We only included experiments executed with monoenergetic beams, as a narrow LET spectra give a better 
description of the LET range of interest compared to beam with broad LET and energy distributions (Dahle et al 
2017). We excluded experiments with LETd above 20 keV µm−1 from our database due to its limited relevance in 
clinical treatments. We further restricted our database to cell experiments where the reference experiment had 
an (α/β)x value below 5 Gy. The latter limit the response from early reacting cells with high (α/β)x values, as our 
database then represented late responding tissue. By only focusing on a narrow range of (α/β)x values, we avoided 
the general (α/β)x dependency and potentially reduced the data noise. Other established models have included 
diverse definitions of the (α/β)x dependency (Carabe et al 2012, McNamara et al 2015, Peeler 2016).
From each experiment, data points were extracted with WebPlotDigitizer (Rohatgi 2018) from the survival 
curve figures. The software was used to calibrate the axes and calculate the dose and survival of each individual 
data point from all experiments. The extraction was restricted to dose versus survival values, omitting potentially 
reported uncertainty bounds as the uncertainty of the data points were not reported in a concise manner and also 
lacking in some studies. The LQ-model was subsequently fitted to each extracted proton experiment in MATLAB 






= −αpDp − βpD2p, (1)
where Dp  is the physical dose deposited by protons per fraction, 
S
S0
 is the survival fraction of the radiated cells 
compared to the reference cells which are not irradiated and αp  and βp  are the radiosensitivity parameters of 
the LQ-model found by the regression. The regression technique was independent of the method applied by the 
study from which the data was extracted. The obtained LQ-model parameters were therefore compared to the 
reported values (figure A1). We used the reported LQ-model parameters of the photon experiments, as the data 
points of the reference experiments were not included in all publications, rendering the refitting of the LQ-model 
Phys. Med. Biol. 64 (2019) 195001 (9pp)
3
E Rørvik et al
difficult (Folkard et al 1989, Prise et al 1990, Schettino et al 2001). From the LQ-model parameters, we found the 




where βp  is our new fitted parameter to the proton data and the βx is the reported parameter of the photon 












Further, to investigate the dependence of the RBEmin on the dose range of the experiments, we refitted the LQ-
model to multiple subsets of the data points of each experiment by introducing two new variables. The first 
dose variable, Dη, is the minimum dose cut-off such that experimental data points lower than this cut-off were 
excluded. The second variable, DΔ, described a margin above Dη such that the experiment must have a dose 
point in the interval of Dη and Dη  +  DΔ to be refitted to the LQ-model. The application of two different Dη 
but identical DΔ is shown in figure 1. The RBEmin derived with equation (2) using the refitted βp -parameter 
from those experiments fulfilling the inclusion variables were used to construct a restricted database. To analyse 
the implication of low dose data (or more importantly, the lack of this data) on the RBEmin function, multiple 
restricted databases were created by varying the Dη from 0 to 2.5 Gy and varying DΔ from 0.2 to 0.7 Gy. The upper 
level of 2.5 Gy was motivated both by the limited amount of available data for higher Dη and the most common 
fraction doses applied in proton therapy.
The RBEmin values were compiled in the restricted databases with the LETd values of the experiments. Based 
on the restricted databases, the simplest form for LETd dependency was explored by the following equation:
RBEmin = 1 + cLETd, (4)
where c is a constant determined from linear regression. Two regression methods were used, as the c value 
was determined with both unweighted and weighted regression. The inverse of the uncertainty, calculated by 
equation (3), was used as weights for the weighted regression. With this relationship, a c-value significantly 
different from 0 indicates that RBEmin has a LETd dependency. We determined the first order c coefficient and its 
uncertainty by both unweighted and weighted regression.
3. Results
From our literature search, we found 76 experiments, each with a specific survival and dose value and a 
corresponding LETd, fulfilling our inclusion criteria (Hei et al 1988, Folkard et al 1989, 1996, Prise et al 1990, 
Belli et al 1993, 1998, Green et al 2001, 2002, Schettino et al 2001, Baggio et al 2002, Schuff et al 2002, Chaudhary 
et al 2014, Guan et al 2015, Patel et al 2017, Howard et al 2018). This corresponded to in total 529 data points, 
Figure 1. Cell survival curves of an experiment with data points extracted from Guan et al (2015). The shaded area is defined by the 
interval of Dη and Dη  +  DΔ. Both figures have an identical DΔ of 0.5 Gy but different Dη of 0 Gy (example A) and 2 Gy (example B). 
The figure illustrates how only data points with a dose value greater or equal to Dη and with a data point located in the shaded area 
are included in the refit, as indicated by the coloured circles around the crosses. If the margin, DΔ, was set smaller, the experiment in 
example A would have failed the inclusion criteria and consequently not been accepted in the restricted database.
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which are shown in figure 2. As seen by the histogram in this figure, the data points of the experiments are mainly 
clustered around integer numbers of Gy and within the dose range of 0.1–10.1 Gy.
The originally reported values of αp  and βp  and those extracted from our refitting procedure using unweighted 
regression to the logarithmic data of cell survival are shown in figure A1. The absolute difference between the 
reported data and refitted data was on average 0.05 (±0.07) Gy−1 for αp  and 0.02 (±0.04) Gy−2 for the βp  value. In 
figure 3, the distribution of the (α/β)x and LETd values of the original (unrestricted) database is shown. As seen, 
the majority of the cell lines have an (α/β)x of 1–4 Gy and the database is dominated by low LETd experiments.
The restricted databases from varying Dη, but keeping DΔ constant (0.5 Gy), is shown in table 1. In general, 
the number of included experiments was greatest around Dη of 0.5 to 1.5 Gy. The effect on varying the margin 
DΔ is shown in table A1, where the number of experiments included in the databases grow as DΔ increased. All 
experiments included in the restricted database have the lowest dose value between Dη and Dη  +  DΔ. By rising 
either of the two parameters, the mean value of the minimum dose value of the included experiment is naturally 
increased, as shown by the table A2.
In table 1 and also illustrated by the figure 1, increasing the Dη resulted in a reduction, and thereby potential 
underestimation, of the βp  parameter. In the example, where a constant DΔ is applied (0.5 Gy), the βp  parameter 
is reduced by more than 50% for Dη of 1.5 Gy or higher as compared to βp  from the unrestricted experiment. The 
βp  parameter is relatively stable for Dη values above 1.5 Gy. Most experiments are refitted if a Dη value between 
0.5 Gy and 1.5 Gy is applied. The implications for αp  are smaller and lacking a clear trend.
From the refitted αp  and βp  parameters the RBEmin value is found with its uncertainty for every experiment 
included in our databases. This is exemplified for three restricted databases with a different number of included 
experiments (figure 4(A) include 34 experiments, figure 4(B) 49 experiments and figure 4(C) 29 experiments). 
Applying linear regression according to equation (4), we find the regression coefficient, c to be small but positive 
for all Dη values. In addition, the c value is decreasing with increasing Dη, which also can be seen in figure 5. Com-
paring the RBEmin values found with unweighted regression to the databases with DΔ  =  0.5 Gy, we find that a 
function derived from a database with Dη  =  0 Gy will calculate an RBEmin value between 1.4  ±  0.1 and 2.5  ±  0.2 
Figure 2. A scatterplot with a corresponding histogram of the data from all experiments fulfilling the criteria of our literature 
search. The red points indicate the minimum dose of each experiment.
Table 1. The mean values of the LQ-model parameters of the included experiments. The mean values for the restricted databases were 
found from varying Dη but with constant margin, DΔ, of 0.5 Gy.
Dη [Gy] Mean αp  [Gy−1] Mean βp  [Gy−2] αp /βp  [Gy]
Number of  
experiments in database Mean lowest dose [Gy]
0.0 0.24 0.20 1.18 34 0.33
0.5 0.28 0.14 2.02 61 0.77
1.0 0.29 0.15 1.94 49 1.20
1.5 0.28 0.09 2.97 58 1.78
2.0 0.30 0.08 3.61 29 2.15
2.5 0.25 0.08 2.85 22 2.80
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in the LETd range from 5 to 20 keV µm−1. These values are significantly smaller for a function derived from a 
database with Dη  =  2 Gy, as the same LETd range will estimate RBEmin values between 1.0  ±  0.1 and 1.1  ±  0.2. 
Hence, if experiments executed with a higher minimum dose was used for estimating RBEmin the LET depend-
ency was diminished.
Furthermore, unweighted regression consistently resulted in a stronger dependency on LETd for RBEmin. A c 
value equal to 0 corresponds to a constant RBEmin independent of LETd. For unweighted regression this required 
a Dη   >  2.0 Gy in combination with a large DΔ and for weighted regression a Dη  >  1.0 Gy in combination with as 
small DΔ. Hence, even for weighted regression and inclusion of doses less than 1 Gy, the results indicate the RBE-
min to be significantly higher than the commonly assumed 1 for high LETd values.
4. Discussion
Our study revealed a clear correlation between the range of doses included in experiments and the variability of 
RBEmin with LETd. Only if data from low doses are excluded from the modelling, the assumption that the RBEmin 
is constant for all with LETd values appears reasonable. When including doses of 1 Gy or less than, our analysis 
shows a small, but significant, increase in RBEmin with increasing LETd. Experiments consisting of data points 
only with high doses could therefore estimate a lower βp  parameter compared to experiments including low dose 
data. This indicates that RBE models which include experiments with high minimum doses could underestimate 
the RBE.
The sensitivity of low doses for the estimation of the βp  parameter could contribute to the diverging results 
on the LETd dependency for RBEmin in the literature. As an example, Guan et al (2015) found both the αp - and 
βp  parameters to be nonlinearly increasing with increasing LETd value. These experiments included low dose 
values, with a minimum dose below 0.5 Gy, as compared to other experiments. In contrast, Chaudhary et al 
Figure 3. The (α/β)x and LETd values of all included experiments, with the corresponding histograms of the total distribution.
Figure 4. The RBEmin values of the experiments in the restricted databases with DΔ  =  0.5 Gy and three different values for Dη: 0 Gy 
(A), 1 Gy (B) and 2 Gy (C).
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(2014) found the βp  parameter to be decreasing with increasing LETd value, which could be caused by their high 
the minimum dose of 1.5 Gy in the experiments, as indicated by the three red circles with at 1.5 Gy in figure 1. 
We hypothesize that the βp  values could have been higher, if the experiment included one or more data points 
with a dose value under 1.5 Gy. Based on our analysis, we therefore recommend that future experiments will be 
performed with low doses included in the experimental setup, with at least one data point with a dose maximum 
equal to 1 Gy, preferably lower.
For our analysis, we included the simplest definition of a variable RBEmin: Variation with a single param-
eter. However, we cannot exclude more a complex relationship between LETd and RBEmin. The definition can 
be modified to abandon the assumption of RBEmin equals 1 at LETd  =  0, by determining the constant from the 
regression analysis. This was done in the models made by Carabe et al (2012), McNamara et al (2015) and Peeler 
(2016). Further, as previously shown for RBEmin, the LET relationship might also be non-linear (Peeler 2016). 
There is however a large variation in the existing data, as seen in figure 4, thus there is no clear non-linear trend. 
More experimental data and verification of existing models, e.g. the comparison of models to experimental data 
by Polster et al (2015) and Mairani et al (2017), needs to be done to determine which model that give the best rep-
resentation of the clinical dose response.
Based on the analysis in this work, we recognise that models with an RBEmin function with a positive depend-
ency of LETd could estimate a more precise RBE and should be explored further. As shown in an earlier analysis of 
phenomenological models (Rørvik et al 2018), the use of a constant RBEmin is inherited from earlier models and 
not based on quantitative analysis of experimental data. Generally speaking, we recommend that new models 
should not adapt a constant definition of RBEmin without performing statistical analysis of the database. Calcul-
ation of the absolute effect of a dose dependent RBEmin on RBE estimates have not been performed, as mixing of 
model functions generally is not recommended.
We chose to focus our RBEmin analysis on late responding tissue by excluding cell lines with an (α/β)x value 
above 5 Gy. This threshold was a compromise between focusing on the late responding tissue, but still having 
sufficient experiments (N  =  76) for our regression analysis. Most models are consistent in their definition of 
the (α/β)x dependency on RBEmax, with an inversely proportional RBEmax with increasing (α/β)x. However, 
the (α/β)x dependency of the RBEmin is deviating in previously published models (Rørvik et al 2018). Carabe 
et al (2012) used the same inversely proportional definition for RBEmin as they did for RBEmax, however the 
experimental database only consisted of V-79 cells with a narrow (α/β)x range around 2–3 Gy. McNamara et al 
(2015) assumed that RBEmin is increasing with the square root of (α/β)x, while Peeler assumed RBEmin to be lin-
ear dependent of the (α/β)x value. We did not include an (α/β)x dependency and omitted the issue altogether by 
analysing a database with a narrow (α/β)x range, mainly between 1 and 4 Gy. We will therefore not postulate if the 
same effect will be seen for early responding tissue with high (α/β)x values, however, our analysis is of interest in 
itself, as most organs at risk are regarded as late responding tissue with low (α/β)x values.
Figure 5. The variation of the regression coefficient, c as a function of Dη for various DΔ values, increasing from subfigure A–F. The 
reported error bars show one standard deviation of the determination of c from regression.
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We introduced a method in our analysis by applying a minimum dose with a margin to construct restricted 
databases from a major database of existing experiments. The refitting of the database with a low margin value, 
excludes many experiments from the regression analysis, as seen in table A1. The quality of the regression analysis 
may therefore be reduced as compared to regression performed on a database constructed with higher margin 
values. Therefore the found regression coefficients should be interpreted carefully due to the small amount of 
data. An effect of the low data amount can be seen in figure 5, where the c values fluctuates for DΔ values up to 
0.5 Gy, while the c values of a DΔ of 0.6 Gy or 0.7 Gy monotonically decreases with increasing LETd value. The 
fluctuations in the mean values are however smaller than the uncertainty, thus we can assume there is a steady 
decreasing trend for all DΔ values. It should be mentioned that the points in figures 4(E) and (F) are based on 
overlapping databases, as the interval between the points (0.5 Gy) is smaller than the DΔ. This will smooth out 
any oscillations in the dataset. We found 0.5 Gy to be a reasonable size for DΔ, as a compromise between having 
enough experiments in the restricted databases but still allowing for separation of the effect from an increasing 
Dη. This value of DΔ is therefore used in the other examples shown in figures 1 and 4 and table 1.
We analysed and treated αp  and βp  as two independent parameters, which is a common practice for LQ-based 
RBE models (Rørvik et al 2018). This is however a major approximation, as a change in one of the parameters 
will be counteracted by the other parameter. The αp  parameter will in general increase when the βp  parameters 
decreases with increasing Dη value. An example of this can be seen by the initially steeper curve in figure 1(B) 
compared to the curve in figure 1(A). Additionally, there is a great variation in the regression fitting techniques 
used in the different experiments reported in the literature, which further impacts the reported LQ-model 
parameters. In an attempt to reduce variations from different regression techniques we refitted the LQ-model 
to the data values with a consistent method for all experiments. Abolfath et al (2017) also omitted this issue by 
making a model directly from data values. They used a ‘global-fitting’ method for the LQ-model parameters, by 
making a regression fit of the LETd dependent αp  and βp  functions in one single regression, instead of treating 
them independently as we did. The ‘global-fitting’ method is novel and could potentially reproduce the actual 
response better, however, Abolfath et al (2017) only adapted the method to two cell lines, independent from each 
other. It is therefore not directly possible to compare the Abolfath model to our model functions in its current 
form. The method needs to be developed further to create a general model from multiple cell lines at once.
In a clinical scenario where a patient is treated with a normal fractionated plan, the practical dose range is 
in between 0 and 2–3 Gy. This is relevant for RBE models, as there should be good correspondence between the 
experimental data of the model and the clinical usage. Therefore, we advise that the dose region of the RBE mod-
els’ background data should be considered relevant in the selection of RBE models. Future RBE models could 
acknowledge the importance of the dose range of the experiments and adapt inclusion criteria for the exper-
imental database accordingly.
5. Conclusion
Based on a compilation of existing in vitro data with (α/β)x values below 5 Gy, RBEmin was found dependent 
on LETd. The small yet significant positive linear correlation of LETd on RBEmin was visible for databases with 
minimum experimental doses of 1 Gy or below. If the minimum dose of the cell survival data was set greater than 
this value, the LETd dependency was lost and RBEmin become constant. The inclusion of experiments with high 
minimum dose in phenomenological RBE models could therefore lead to underestimation of the actual proton 
RBE.
Acknowledgments
This work was funded by Bergen Research Foundation.
Appendix
The value and uncertainty of the αp  and βp  parameters of the different experiments are given in figure A1. The 
refitted values shown are found from a refit to all data points of the experiment, not only a restricted selection 
of data points with high dose values. The variation of the reported and refitted parameters arises from different 
fitting techniques, as we only used a linear regression technique. Some articles used the uncertainty in the data in 
a weighted regression technique. As our database is found from figures, not reported values, this can also explain 
the difference in figure A1.
By varying Dη and DΔ values, the number of experiments included in the restricted will also vary, as shown 
in table A1. The number increases with the width of the dose margin (DΔ) and is largest for Dη between 0.5 and 
1.5 Gy. The variation of the parameters also varies the dose values of the included experiments. The actual mean 
minimum dose is given in table A1.
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